11.43 +0.06 (0.52%)
ALKS
Stock Details
Last Trade:11.43 Change:+0.06 (0.52%) Prev Close:11.37 Open: 11.56 Days Range:11.40 – 11.68 52 Week Range: 7.41 - 13.16 Volume:1086280 P/E: 13.61EPS:0.84
View AllRecent Alerts 02/09/10
Recent Alert on 02/05/10 at 10:45am
Notable Analyst rating Changes for 02/05: RMD, WFR, ALKS, SFN, BEBE Upgraded; FWD, EGOV, LEAP, COH, CIEN Downgraded
Notable Analyst rating Changes for 02/05: RMD, WFR, ALKS, SFN, BEBE Upgraded; FWD, EGOV, LEAP, COH, CIEN Downgraded
UPGRADES Wells Fargo upgrades ResMed Inc. (NYSE: RMD) from Underperform to Market Perform. Valuation range increased from $45-47 to $53-58. Click Here for more color. MEMC Electronic (NYSE: WFR) upgraded by two firms:Credit Suisse ups to... Read More
Recent Alert on 02/04/10 at 9:28am
Alkermes (ALKS) Announces Development of LinkeRx for Injectible XR Versions of Antipsychosis and Other CNS Therapies
Alkermes (ALKS) Announces Development of LinkeRx for Injectible XR Versions of Antipsychosis and Other CNS Therapies
Recent Alert on 02/04/10 at 9:28am
Alkermes (ALKS) Announces Development of LinkeRx for Injectible XR Versions of Antipsychosis and Other CNS Therapies
Alkermes (ALKS) Announces Development of LinkeRx for Injectible XR Versions of Antipsychosis and Other CNS Therapies
Recent Alert on 01/26/10 at 8:37am
Amlylin Pharma (AMLN): Upgraded to Buy at Citigroup; Street high target of $27
Amlylin Pharma (AMLN): Upgraded to Buy at Citigroup; Street high target of $27
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available